Published on: July 28, 2017 at 12:00PM
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Cancer; Non-Small Cell Lung Cancer
Interventions: Drug: Decitabine (DAC); Drug: Tetrahydrouridine (THU); Drug: Pembrolizumab
Sponsor: National Cancer Institute (NCI)
Not yet recruiting – verified July 21, 2017
http://ift.tt/2uctiOZ
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM